Disclaimer: This is an early beta prototype. If you find any error, with data or functionality, please let us know via this page.
Registration date period
Results ordered by trial registration date, descending.
  1. Peer mentorship in osteoarthritis

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Not recruiting
    Source name:
    ISRCTN

    Background and study aims Osteoarthritis (OA) is the most common form of arthritis. It occurs when the protective cartilage on the end of bones wears away, causing the bones to rub against one...

    Conditions:
    • Specialty: Musculoskeletal disorders, Primary sub-specialty: Non-inflammatory Joint Disorders; UKCRC code/ Disease: Musculoskeletal/ Arthrosis
    Interventions:

    Unknown

  2. Intraocular injection conbercept is safe and effective to improve vision, relieve symptoms for patients suffered from choroidal neovascularization secondary to punctate inner choroidopathy

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Not recruiting
    Source name:
    ISRCTN

    Background and study aims Punctate inner choroidopathy (PIC) is eye disease that affects the choroid (connective tissue layer of the eye) and the retina (the part of the eye where light signals are...

    Conditions:
    • Active subfoveal or juxatoveal CNV secondary to punctate inner choroidopathy
    Interventions:
    • Conbercept
  3. Cold air, physical activity and the airways

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Recruiting
    Source name:
    ISRCTN

    Background and study aims Studies have shown that exposure to sub-zero temperatures is associated with increased morbidity (illness) and mortality (death). People with lung diseases are a particularly...

    Conditions:
    • Airway injury
    Interventions:

    Unknown

  4. Multicentric, Open-label, Randomized, Parallel-group Study to Evaluate the Efficacy and Safety of Omalizumab in a 12-MonthPeriod, in Patients with Severe IgE-mediated Asthma Inadequately Controlled with High Doses of Corticosteroids. MEXIC Study

    Registration date:
    Status:
    Unknown
    Recruitment status:
    Unknown
    Source name:
    EU Clinical Trials Register

    To assess efficacy and safety of omalizumab treatment during 12 months in order to reduce the use of inhaled corticosteroid (ICS) in pediatric and adult patients with severe IgE-mediated asthma...

    Conditions:
    • Difficult to control severe asthma
    Interventions:
    • XOLAIR
  5. Roflumilast and cognition in memory-impaired elderly

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Not recruiting
    Source name:
    ISRCTN

    Background and study aims With increasing age, more and more people are having problems with their memory, attention, planning and learning ability. This can often be a sign of a common condition...

    Conditions:
    • Dementia
    Interventions:

    Unknown

  6. Effects of fish consumption on cardiovascular risk factors

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Not recruiting
    Source name:
    ISRCTN

    Background and study aims Consuming fish is a good source of omega-3 fatty acids. Omega-3 fatty acids are good for the heart and can help those who are at high risk of cardiovascular disease (CVD)....

    Conditions:
    • Cardiovascular Diseases
    Interventions:

    Unknown

  7. Epigenetic mechanisms linking a mothers’ nutrition to the health of her children in India and Sub-Saharan Africa

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Recruiting
    Source name:
    ISRCTN

    Background and study aims Maternal nutrition before and during pregnancy is very important and can impact the health of the baby. This study, known as the EMPHASIS study, is a joint initiative between...

    Conditions:
    • DNA methylation, growth, body composition, neuro-development, cardio-metabolic risk, bone health
    Interventions:

    Unknown

  8. Essai multicentrique, randomisé, contrôlé, comparant l'immunogénicité et la tolérance de deux stratégies innovantes de vaccination anti-pneumococcique au schéma de vaccination standard chez des patients atteints de vascularites associées à des ANCA et devant recevoir un traitement par rituximab

    Registration date:
    Status:
    Ongoing
    Recruitment status:
    Unknown
    Source name:
    EU Clinical Trials Register

    L'objectif principal de cet essai est de comparer l'immunogénicité au mois 6 (M6) de deux schémas de vaccination renforcée innovants contre le pneumocoque (une double ou quadruple doses de PCV13...

    Conditions:
    • Patients with ANCA-associated vasculitides treated with rituximab therapy
    Interventions:
    • Prévenar 13®
    • Pneumo-23